Residual disease after re-excision for tumour-positive surgical margins in both ductal carcinoma in situ and invasive carcinoma of the breast: The effect of time

被引:8
|
作者
Van Der Velden, A. P. Schouten
Van De Vrande, Simon L. B.
Boetes, Carla
Bult, Peter
Wobbes, Theo
机构
[1] Radboud Univ Nijmegen, Nijmegen Med Ctr, Dept Surg Oncol, NL-6500 HB Nijmegen, Netherlands
[2] Radboud Univ Nijmegen, Nijmegen Med Ctr, Dept Radiol, Nijmegen, Netherlands
[3] Radboud Univ Nijmegen, Nijmegen Med Ctr, Dept Pathol, Nijmegen, Netherlands
关键词
breast carcinoma; ductal carcinoma in situ; residual disease;
D O I
10.1002/jso.20876
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background and Objectives: To assess the effect of time on finding residual breast cancer in re-excision specimens after non-radical breast-conserving surgery for both DCIS and invasive breast carcinoma. Methods: 315 breast-conserving surgical procedures with tumour-positive margins were retrospectively reviewed. The significance of association between the presence of finding residual tumour in the re-excision specimen and mean time interval was calculated with Student's t-test. A multivariate logistic regression model was used to assess the independent relative risk of time on presence of residual tumour. Results: Residual tumour was found in 240 (76.2%) of the re-excision specimens. For primary invasive carcinomas time was a risk-reducing factor for finding residual disease (OR 0.89, 95% CI 0.82-0.98, P = 0.01). If invasive carcinoma was transected, the absence of residual disease was significantly related with a longer mean time interval (OR 0.98, 95% CI 0.95-0.99, P = 0.04). Conclusions: An increased time interval between primary surgery and re-excision for turnour-positive surgical margins for invasive carcinoma is associated with a decreased incidence of finding residual tumour. This could be explained by inflammatory responses after surgical trauma. For DCIS there was no influence of time on finding residual tumour, which could be explained by a more protective microenvironment of DCIS or re-growth of surviving malignant cells.
引用
收藏
页码:569 / 574
页数:6
相关论文
共 50 条
  • [31] Residual Disease in Re-Excision Partial Mastectomy (PM) for Positive Margins in Breast Conservation Therapy
    Deladisma, A. M.
    Arriagada, P.
    Greer, L. T.
    Rosman, M.
    Mylander, C.
    Buras, R. R.
    Tafra, L.
    Liang, W.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2012, 19 : S94 - S94
  • [32] Predictive factors for positive surgical margins in the treatment of breast ductal carcinoma in situ
    Hassan, Rafael A. M.
    Maesaka, Jonathan Y.
    Ricci, Marcos D.
    Soares, Jose M., Jr.
    Doria, Maira Teixeira
    Baracat, Edmund C.
    Filassi, Jose R.
    [J]. JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2016, 12 (02) : 995 - 998
  • [33] Risk of local failure in breast cancer patients with lobular carcinoma in situ at the final surgical margins: Is Re-excision necessary?
    Sadek, Betro T.
    Shenouda, Mina N.
    Abi Raad, Rita F.
    Niemierko, Andrzej
    Keruakous, Amany R.
    Goldberg, Saveli I.
    Taghian, Alphonse G.
    [J]. International Journal of Radiation Oncology Biology Physics, 2013, 87 (04): : 726 - 730
  • [34] Risk of Local Failure in Breast Cancer Patients With Lobular Carcinoma In Situ at the Final Surgical Margins: Is Re-excision Necessary?
    Sadek, Betro T.
    Shenouda, Mina N.
    Raad, Rita F. Abi
    Niemierko, Andrzej
    Keruakous, Amany R.
    Goldberg, Saveli I.
    Taghian, Alphonse G.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (04): : 726 - 730
  • [35] Rate of Re-excision after Breast-conserving Surgery for Invasive Lobular Carcinoma
    Wanis, Morcos L.
    Wong, Jennifer A.
    Rodriguez, Samuel
    Wong, Jasmine M.
    Jabo, Brice
    Ashok, Arjun
    Lum, Sharon S. J.
    Solomon, Naveenraj L.
    Reeves, Mark E.
    Garberoglio, Carlos A.
    Senthil, Maheswari
    [J]. AMERICAN SURGEON, 2013, 79 (10) : 1119 - 1122
  • [36] Relationship between size of ductal carcinoma in situ and margin status to residual disease in subsequent re-excision or mastectomy specimens.
    Cheng, L
    AlKaisi, NK
    Gebrail, F
    Gordon, NH
    [J]. LABORATORY INVESTIGATION, 1996, 74 (01) : 70 - 70
  • [37] Residual disease after excision of ductal carcinoma in situ of the breast: a multivariate regression analysis of predictive factors
    Jenkins, J. T.
    Mansell, J.
    Wilson, C. R.
    Mallon, E. A.
    Doughty, J. C.
    George, W. D.
    [J]. EJC SUPPLEMENTS, 2007, 5 (03): : 7 - 7
  • [38] Adjuvant radiation or re-excision for early stage vulvar squamous cell carcinoma with positive or close surgical margins
    Bedell, S. M.
    Hedberg, C.
    Pearson, H.
    Griffin, A.
    Bangdiwala, A.
    Erickson, B. K.
    [J]. GYNECOLOGIC ONCOLOGY, 2019, 154 : 233 - 233
  • [39] Effect of the Ductal Carcinoma In Situ Margin Consensus Guideline Implementation on Re-Excision Rates, Satisfaction, and Cost
    Bhutiani, Neal
    Holland, Michelle M.
    Mercer, Megan K.
    Donaldson, Marilyn
    Berry, Tiffany S.
    McMasters, Kelly M.
    Ajkay, Nicolas
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (12) : 7432 - 7438
  • [40] Effect of the Ductal Carcinoma In Situ Margin Consensus Guideline Implementation on Re-Excision Rates, Satisfaction, and Cost
    Bhutiani, Neal
    Ajkay, Nicolas
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2020, 231 (04) : S37 - S37